» Articles » PMID: 37749369

Glucagon-like Peptide-1 and Glucagon-like Peptide-2 Regulation During Human Liver Regeneration

Overview
Journal Sci Rep
Specialty Science
Date 2023 Sep 25
PMID 37749369
Authors
Affiliations
Soon will be listed here.
Abstract

Accumulating evidence suggests that metabolic demands of the regenerating liver are met via lipid metabolism and critical regulators of this process. As such, glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2) critically affect hepatic regeneration in rodent models. The present study aimed to evaluate potential alterations and dynamics of circulating GLP-1 and GLP-2 in patients undergoing liver resections, focusing on post-hepatectomy liver failure (PHLF). GLP-1, GLP-2, Interleukin-6 (IL-6) and parameters of lipid metabolism were determined perioperatively in fasting plasma of 46 patients, who underwent liver resection. GLP-1 and GLP-2 demonstrated a rapid and consistently inverse time course during hepatic regeneration with a significant decrease of GLP-1 and increase of GLP-2 on POD1. Importantly, these postoperative dynamics were significantly more pronounced when PHLF occurred. Of note, the extent of resection or development of complications were not associated with these alterations. IL-6 mirrored the time course of GLP-2. Assessing the main degradation protein dipeptidyl peptidase 4 (DPP4) no significant association with either GLP-1 or -2 could be found. Additionally, in PHLF distinct postoperative declines in plasma lipid parameters were present and correlated with GLP-2 dynamics. Our data suggest dynamic inverse regulation of GLP-1 and GLP-2 during liver regeneration, rather caused by an increase in expression/release than by changes in degradation capacity and might be associated with inflammatory responses. Their close association with circulating markers of lipid metabolism and insufficient hepatic regeneration after liver surgery suggest a critical involvement during these processes in humans.

Citing Articles

Plasma GLP-1 and metabolic dynamics during human liver regeneration and their association with posthepatectomy liver failure.

Ammann M, Jonas J, Pereyra D, Santol J, Hackl H, Kalchbrenner T Hepatobiliary Surg Nutr. 2025; 14(1):49-65.

PMID: 39925909 PMC: 11806138. DOI: 10.21037/hbsn-24-464.


Lipid regulation of the glucagon receptor family.

Oqua A, Manchanda Y, McGlone E, Jones B, Rouse S, Tomas A J Endocrinol. 2024; 261(3).

PMID: 38614123 PMC: 11103681. DOI: 10.1530/JOE-23-0335.

References
1.
Lazarus J, Newsome P, Francque S, Kanwal F, Terrault N, Rinella M . Reply: A multi-society Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023; 79(3):E93-E94. DOI: 10.1097/HEP.0000000000000696. View

2.
Sparrelid E, Olthof P, Dasari B, Erdmann J, Santol J, Starlinger P . Current evidence on posthepatectomy liver failure: comprehensive review. BJS Open. 2022; 6(6). PMC: 9681670. DOI: 10.1093/bjsopen/zrac142. View

3.
Hsieh J, Longuet C, Maida A, Bahrami J, Xu E, Baker C . Glucagon-like peptide-2 increases intestinal lipid absorption and chylomicron production via CD36. Gastroenterology. 2009; 137(3):997-1005, 1005.e1-4. DOI: 10.1053/j.gastro.2009.05.051. View

4.
Koehler J, Kain T, Drucker D . Glucagon-like peptide-1 receptor activation inhibits growth and augments apoptosis in murine CT26 colon cancer cells. Endocrinology. 2011; 152(9):3362-72. DOI: 10.1210/en.2011-1201. View

5.
Ellingsgaard H, Hauselmann I, Schuler B, Habib A, Baggio L, Meier D . Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med. 2011; 17(11):1481-9. PMC: 4286294. DOI: 10.1038/nm.2513. View